STEVE PAKOLA
CIK 1700659 · Chief Medical Officer · last filed 2026-05-13
STEVE PAKOLA is a Chief Medical Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $168.7K of RGNX on May 13, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.55M
2
17
-$1.01M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Medical Officer | 232,617 | $6.66 | $1.55M | -$1.01M | 15 | 2026-05-13 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Chief Medical Officer | — | $33.00 | — | $0 | 1 | 2019-02-20 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-13 | RGNX | Sell (S) | −15,309 | -$168.7K | EDGAR |
| 2026-03-12 | RGNX | Sell (S) | −5,124 | -$53.0K | EDGAR |
| 2026-02-03 | RGNX | Tax (F) | −5,267 | -$58.8K | EDGAR |
| 2026-01-08 | RGNX | Grant (A) | +65,847 | $0 | EDGAR |
| 2026-01-06 | RGNX | Tax (F) | −18,247 | -$262.8K | EDGAR |
| 2025-04-04 | RGNX | Tax (F) | −5,263 | -$42.5K | EDGAR |
| 2025-01-06 | RGNX | Mixed | +50,402 | -$107.4K | EDGAR |
| 2024-08-05 | RGNX | Grant (A) | +58,386 | $0 | EDGAR |
| 2024-03-07 | RGNX | Mixed | — | -$78.7K | EDGAR |
| 2024-01-04 | RGNX | Mixed | +4,429 | -$486.2K | EDGAR |